GNH USA

Europe — EMA

Neurapas

GNH USA supplies Neurapas (Dry Extract Of St. John's Wort), a herbal antidepressant for mild to moderate depression and mood disorders.

Dry Extract Of St. John's Wort (4,6-6,5:1), Extraction Solvent: Ethanol 38% M/M, Dry Extract Of Vale

Request sourcing

1
Pack/s

What is Dry Extract Of St. John's Wort (4,6-6,5:1), Extraction Solvent: Ethanol 38% M/M, Dry Extract Of Vale?

Dry Extract Of St. John's Wort, the active ingredient in Neurapas, is a herbal antidepressant presented as an oral herbal preparation for oral use. It is used to support mood balance and to alleviate symptoms of mild to moderate depression in adults.

GNH USA supplies Neurapas as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

What is Dry Extract Of St. John's Wort (4,6-6,5:1), Extraction Solvent: Ethanol 38% M/M, Dry Extract Of Vale used for?

Neurapas is an herbal antidepressant that acts on neurotransmitter pathways associated with mood regulation. - Mild to moderate depression: helps reduce depressive symptoms and improve overall mood. - Mood disorders: supports emotional stability in conditions such as dysthymia. - Seasonal affective disorder: may alleviate low mood linked to seasonal changes.

What are the side effects of Dry Extract Of St. John's Wort (4,6-6,5:1), Extraction Solvent: Ethanol 38% M/M, Dry Extract Of Vale?

Neurapas may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal upset: nausea, stomach discomfort. - Skin reactions: mild rash or itching. - Fatigue or dizziness. - Headache. - Insomnia or vivid dreams.

Serious or Rare Side Effects: - Photosensitivity: increased sensitivity to sunlight. - Serotonin syndrome when combined with other serotonergic agents. - Severe allergic reaction: swelling, difficulty breathing. - Hyponatremia in susceptible individuals. - Liver enzyme elevation in rare cases.

What precautions apply to Dry Extract Of St. John's Wort (4,6-6,5:1), Extraction Solvent: Ethanol 38% M/M, Dry Extract Of Vale?

Before using Neurapas, consider the following safety measures. - Pregnancy: safety not established; consult a healthcare professional. - Breastfeeding: potential transfer to infant; discuss with a clinician. - Existing psychiatric conditions: use under medical supervision. - Concomitant medications: review possible interactions with a pharmacist. - Underlying liver or kidney disease: monitor function regularly. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

What does Dry Extract Of St. John's Wort (4,6-6,5:1), Extraction Solvent: Ethanol 38% M/M, Dry Extract Of Vale interact with?

Neurapas can affect the activity of several other medicines.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): heightened serotonergic effects. - Anticoagulants (e.g., warfarin): increased bleeding risk. - Cyclosporine and indinavir: reduced plasma concentrations.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: possible additive serotonergic activity. - Oral contraceptives: decreased efficacy, consider alternative methods. - Anticonvulsants (e.g., carbamazepine): may lower drug levels. - Digoxin: potential reduction in therapeutic effect.

Frequently asked questions

What is Neurapas used for?+
Neurapas is an oral herbal preparation containing a dry extract of St. John's Wort. It is used to support mood balance and to alleviate symptoms of mild to moderate depression and other mood disorders in adults.
How does the dry extract of St. John's Wort work?+
The extract modulates neurotransmitter activity by inhibiting serotonin reuptake and influencing dopamine and norepinephrine pathways, which increases the availability of these mood‑regulating chemicals in the brain and contributes to an antidepressant effect.
What is the usual dose of Neurapas?+
The appropriate dose of Neurapas is determined by the prescribing healthcare professional based on the individual’s condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not self‑adjust the dosage.
Is Neurapas safe during pregnancy or breastfeeding?+
Safety of Neurapas in pregnancy and lactation has not been established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.
How do I order Neurapas from GNH USA?+
To order Neurapas, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.
How does Neurapas compare with other antidepressants?+
Neurapas is a herbal antidepressant, whereas many alternatives are synthetic pharmaceuticals such as SSRIs or SNRIs. It works by modulating multiple neurotransmitter pathways and may have a different side‑effect profile, but efficacy and safety should be evaluated individually with a clinician.
How should Neurapas be stored and handled?+
Neurapas should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and potency.
How is Neurapas administered?+
Neurapas is taken orally, typically with water. The exact administration schedule, including timing relative to meals, should be directed by the prescribing healthcare professional.
What are the most serious risks associated with Neurapas?+
Serious risks include photosensitivity, serotonin syndrome when combined with other serotonergic agents, severe allergic reactions, and rare liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, difficulty breathing, or signs of serotonin excess.
Who should not use Neurapas?+
Neurapas should be avoided by individuals taking MAO inhibitors, certain antidepressants, anticoagulants, or medications that interact significantly with St. John's Wort. It is also contraindicated in people with known hypersensitivity to Hypericum perforatum or its excipients.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Dry Extract Of St. John's Wort (4,6-6,5:1), Extraction Solvent: Ethanol 38% M/M, Dry Extract Of Vale
Route
Oral Use
Manufacturer
Pascoe Pharmazeutische Präparate Gmbh
Origin
EU